Topical ttll-trans retinoic acid (RA) is efficacious for the treattnent of various skin disorders, including acne' and photoageing." It is accepted that RA is beneficial in acne due to the nortnalizatioti of follicular duct keratitiocyte differentiation. However, the mechanism of action of RA in the improvement of clinical features of photoageing, namely wrinkling and aclinic lentigines, is still controversial. This situation has arisen because the cutaneous erythema and scaling (retinoid dermatitis), associated with the use of topical RA, raises the possibility that RA is acting solely as a local irritant and that its actions are not an inherent property of the RA molecule. In addition, 4~day treatment of normal skin with RA, under occlusion, produces epidermal histological changes very similar to those produced by sodium lauryl sulphate (SLS) under the same conditions.' However. RA produces changes not seen in SLS-treated skin. e.g. the induction of cellular retinoic acid binding protein II (CRABP-II)"* and the induction of RA 4-hydroxylase activity, both of which are important in RA metabolism.
At the cell surface, monosaccharides are linked together in different sequences by different glycosidic linkages, thereby generating a vast number of complex saccharide chains'' ' (Fig. 1) . In the stratified epithelia of skin and oral mucosa. the cellular differentiation process is characterized by a stepwise synthesis of cell surface carbohydrates.^'' The different types of stratitied epithelium have their own specilic pattern of carbohydrate expression, which may vary in relationship to certain physiological and pathological conditions.'" ' "Î I appears that RA-treated epidermis takes on some of the characteristics of mucosal epithelia, i.e. glycosaminoglycan accumulation '' and the expression of keratin 13. *' Expression of glycosyltransferases. which are responsible for the synthesis of cell surface carbohydrate chains, is changed in vitro by RA,'' indicating that RA may ultimately regulate the expression of cell surface carbohydrates. In the light of these observations, and in an attempt to further characterize the differences betweeti RA and SLS-trealed skin, we examined the ability of these two compounds to modulate the expression of epidermal cell surface carbohydrates, i.e. the glycosylation pattern.
Materials and methods

Pttticnts
Seven normal volunteers (age range 3 5-45 years) were treated on three separate areas of the hips or buttocks with single applications of ()-l% RA cream (Retin-A-, Ortho Pharmaceutical Corp., Raritan. NJ. U.S.A.) colour-matched, vehicle cream (Ortho), or 2% SLS (Dupouol-C, Dupont Co., Wilmington. DE, U.S.A.) formulated in Retin-A vehicle cream. The treated areas were occluded with light-tighl plastic for 4 days. We havepreviously demonstrated lhal()-l%RA and 2% SLS creams produce almost identical erythema and epidermal histological changes under these treattnent conditions.' At 4 days, the occlusion was removed and 4-tnm punch biopsies taken from all treatment sites under 1% lignocaine anaesthesia. The bi<jpsies were snap frozen in liquid nitrogen and stored at -70 C until use.
All volunteers gave written consent and the protocol was approved by the University of Michigan Medical Center Institutional Review Board.
Immtmochemistrij
Five-micrometer cryostat sections were air-dried and stained using a double-layer technique'" with wellcharacterized monoclonal antibodies to carbohydrate epitopes (Table 1) .'^""' In brief, frozen sections were air-dried and incubated in a moist chamber with a monoclonal antibody lor 1 S h at 4 C. Following ihree washes in phosphate-buffered saline (PBS) pH 72 (5 min each), fiuorescein isothiocyanate (FITC)-conjugated rabbit anti-mouse immunoglobulin, diluted Tnhk-I. I'iini'l of mouse monoclontil antibotlics used (ii) substitution of the primary monoclonal antibody with monoclonal antibodies of irrelevant .specificity hut of the same isotype: and (iii) substitution of the primary antibody with culture supernatant from the myeloma line (Sp2/()| used for hybridization, so as to control for the culture medium and nonspecific secretions from the myeloma cell line.
Quantification of staining
Epidermal thickness was graded from 2 (normal thickness) to a maximum of fi. Epidermal T antigen expression was graded on a 0-3 scale where 0 is staining of 0-1 cell layers: 1. 2-4 layers: 2. >4 hut not all cell layers: and 3, staining of entire epidermis. Epidermal Le^ expression was also graded on a 0-3 scale, where 0 is no staining: 1. 1 superficial ceU layer (granular layer): 2. 2-3 superficial cefi layers (granular and upper spinous): and 3. >3 cell layers stained.
Stdtistical inelJiods
The sign test was used to compare the presence or absence of staining among treatments for T antigen as well as I^e-^. The Friedman rank sum and multiple comparison tests were used to compare group differences iti epithelial thickness. All P-values are two-sided. Summary statistics are expressed as means ± standard error of the mean (SEM). The data were analysed wilh the Michigan hileractive data analysis system, a statistical software package developed by the Center for Statistical Consultation and Research at the University of Michigan.
Results
As previously observed.' both RA and SLS treatments thickened the epidermis. However, there was no significant difference between the epidermal thickness of RA and SLS-treated skin ( Table 2) . Type 1 chain structures (Le" and Le ) could not be demonstrated in vehicle-. SLS-or RA-treated skin. H antigen, which is a precursor of Le^\ was not seen in RA-treated tissue but was present in the granular cell layer of vehicle-and SLS-treated skin, whereas JV-acetyllactosamine. the precursor of H antigen, was weakly expressed in all samples, Pretreatment with neuraminidase showed strong staining in the spinous cell layer, indicating that most of the N-acetyllactosamine is masked by sialic acid. We could not demonstrate Le" in any biopsies. However, sialylated Le'' was seen in all biopsies, as cell surface staining on epidermal dendritic cells, most probably Langerhans cells, as has been described previously.^*'^^ Le*. a type 2 chain structure, was not observed in either vehicle-or SLS-treated skin, but was strongly expressed as keratinocyte cell surface staining in the upper epidermis of RA-treated skin (Table 2 : Fig. 2) . T antigen, a type 3 chain structure, was expressed throughout the epidermis in vehicle-and SLS-treated skin but was only observed in the granular layer of RA-Lreated epidermis (P ^ 0 ()3. Table 2 . Fig.  2 ).
All other carbohydrate structures investigated showed no differences between RA-. SLS-and vehicle-treated skin, and were distributed as described previously.**' ' ** Discussion Cell surface carbohydrates are of considerable interest in studies of epithelial cells because these structures vary markedly with important cellular processes such as development, differentiation, and oneogenic transformation.^"'"^ In stratified epithelium, basal cells express short and unbranched carbohydrates whereas suprabasal layers express carbohydrates with longer structures.' Changes in expression of cell surface carbohydrates may be due to changes in glycosyltransferase activity or to competition between different glycosyltransferases for a cotnmon substrate.''' As terminal portions of carbohydrates are strongly inimunogenic. it is possible to raise antibodies useful for their identification."*" Different carbohydrate terminal structures are termed types 1. 2, 3 and 4."' and these structures have different tissue distributions. Types 1. 2. and 5 are found in non-keratinized (mucosal) epithelium."^ whereas only types 2 and 3 are found in keratinized epithelium.
Previous work ^ has shown a mucosal-!ike expression of keratin, involucrin and epidermal transglutaminase in RA-treated skin. i.e. expression of keratin 1 J and precocious suprabasa! expression of involucrin and epidermal transglutaminase. Thus, our current study supports the concept of RA-lreated skin assuming the phenotype of a mucosa! epithelium.
We studied three groups of carbohydrate structures with well-known biosynthetic precursor product relationships, including types 1. 2 and mucin-type 3 i'igure 2. Retinoic Hcid (RA) alters expression of cell surface carhohydrates in human epidermis. Vehicle, 2% sodium lauryl sulphate (Sl^) and 0-1% RA creams were applied lopically to normal skin and occluded for 4 days. Sections from vehicle (a and d). SlU (h and el and R,'\ (cand f) treated skin were stained with an immunolluorescence method to detect cell surface carbohydrates, (a-cl represent .sections stained with antibody to T antigen. whereas I d-f) represent sections stained with antibody to Le*". Positive epidermal keralinocyte cell surface staining is idenliliable as green 'chickenwire', whereas non-specific, background staining, is yellow. In RA-treated epidermis, T antigen is only present on the mosi superllcial cells in tho spinous cell layer (ci, whereas in vehicle (a) and SI,S-treated epidermis (b) T antigen is present on all spinous cells. U'^ is only expressed in RA-treated epidermis (f | and is not expressed in either vehicle (d) or SLS-treated epidermis (e) (x5()). chain, in skin treated with either RA. SLS or a nonirritant vehicle. We found that distribution of carbohydrale structures in SLS and vehicle-treated epidermis corresponds to that seen in the normal epidertnis. Type 1 chain structures that are normally expressed only in mucosal epithelium^ ' "* were not found in any ofthe skin samples. However, type 2 and 3 chains showed some mucosa-iike expression in RA-treated skin. In normal stratified epithelium there is a sequential expression of type 2 chain N-acetyllactosamine. H antigen and bkH)d group A and B antigens in A-and B-positive individuals.'^'" However, in RA-treated skin, the epidermis expressed Le^ (Fig. 2) , which is a fucosylsubsliliited version of the H antigen not present in normal epidermis but strongly expressed in mucosal epithelitim,'" ""^ H antigen, which is found in normal epidertnis, could not be detected in RA-treated epidermis. Aciivity of the enzymes required for synthesis of H antigen and Le^ has previously been demonstrated in normal epithelium.'' '" However, these activities have been expressed in different cell layers and. therefore, did not result in expression of Le-^ but in two precursor structures." namely Le" and H (Fig. 2) . The present work demonstrates that RA-treated skin has an alteration in the differentiation pattern, thereby leading to expression of X and H enzymes in the same cells, and leading to a new cell surface carbohydrate structure, i.e. Le^.
T antigen is an O-Iinked. mucin-Iike. carbohydrate structure. "
hi the nortnal epidermis. T antigeti is found on spinous and. to some extent, basal cells.^ but following RA treatment, it could only be demonstrated in the granular cell layer. Attempts to demonstrate the precursor structures of T antigen (Tn and sialosyl-Tn) in the basal and spinous cell layers failed. We believe that T antigen in basal and spinous cell layers in RA-treated tissue is masked by branching and elongation of carbohydrate structures, thereby leading to a mucin-type glycosylation."' an observation which would be in agreement with other studies indicating a mucous type of differentiation after retinoid treatment.''^^ This hypothesis is supported by studies ofthe effects of RA on a mouse teratocarcinoma cell line. F9. ' Such studies have shown that RA treatment induces differentiation of F^J cells into primitive endoderm-iike cells, associated with upregulation of N-acelylglucosamitie-tratisferases which are responsible for synthesis of cell surface O-Iinked polylactosamine. A polylactosatnine elongation t)f T antigen will block tissue staining with anti-T antibodies, and could lead to some of the changes in cell surface carbohydrates observed in RA-treated skin. The eflect of retinoids on expression of other glycosyltransferases is at present unknown.
In summary, we detnonstrate that the glycosylation pattern of SLS-treated epidermis is not significantly different from that seen in normal skin and that RAtreated epidermis strongly expresses Le^ and minimally expresses T antigen-features of mucosal epithelia. These observations are compatible with the idea that topical RA and irritants have differing effects on the epidermis.
